Amyloid β protein injection into medial septum impairs hippocampal long-term potentiation and cognitive behaviors in rats

Sheng Li Xue Bao. 2018 Jun 25;70(3):217-227.

Abstract

The specific loss of cholinergic neurons and the progressive deficits of cognitive function are the most primary characteristics of Alzheimer's disease (AD). Although the neurotoxicity of amyloid β protein (Aβ) in AD has been investigated extensively, it is still unclear whether the Aβ aggregated in the medial septum (MS), a major cholinergic nucleus projecting to the hippocampus, could affect hippocampal synaptic plasticity and further impair the memory behaviors. The present study investigated the effects of Aβ injection into the MS on hippocampal long-term potentiation (LTP) and cognitive behaviors of rats by using Morris water maze (MWM), Y maze and in vivo hippocampal LTP recording. The effects of kainic acid (KA), an agent with specific neurotoxicity to GABAergic neurons, were also observed. The results showed that: (1) Intra-MS injection of Aβ25-35, not KA, impaired spatial learning and memory of rats in classical and reversal MWM tests; (2) Both Aβ25-35 and KA impaired novelty-seeking behavior of rats in Y maze; (3) Intra-MS injection of Aβ25-35, not KA, suppressed in vivo hippocampal LTP in the CA1 region of rats; (4) Both Aβ25-35 and KA did not affect the motor ability in behavioral tests and the hippocampal paired-pulse facilitation (PPF) in electrophysiological recording. These results indicate that intra-MS injection of Aβ could impair spatial memory, cognitive flexibility and exploratory motivation, as well as hippocampal LTP in rats, suggesting that the cholinergic neurons in the MS and the septo-hippocampal projection could be important targets of neurotoxic Aβ, and the specific damage of cholinergic neurons in the MS is likely responsible for the impairments of hippocampal synaptic plasticity and cognitive function in AD.

MeSH terms

  • Alzheimer Disease
  • Amyloid beta-Peptides / adverse effects*
  • Animals
  • Cognition*
  • Hippocampus / physiopathology*
  • Kainic Acid / adverse effects
  • Long-Term Potentiation*
  • Maze Learning
  • Memory Disorders
  • Neuronal Plasticity
  • Peptide Fragments / adverse effects*
  • Rats
  • Spatial Learning
  • Spatial Memory

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • amyloid beta-protein (25-35)
  • Kainic Acid